Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 42

1.

The genetic basis for inactivation of Wnt pathway in human osteosarcoma.

Du X, Yang J, Yang D, Tian W, Zhu Z.

BMC Cancer. 2014 Jun 18;14:450. doi: 10.1186/1471-2407-14-450.

PMID:
24942472
[PubMed - in process]
Free PMC Article
2.

Differential expression of cysteine dioxygenase 1 in complex karyotype liposarcomas.

Shaker M, Pascarelli KM, Plantinga MJ, Love MA, Lazar AJ, Ingram DR, von Mehren M, Lev D, Kipling D, Broccoli D.

Biomark Cancer. 2014 Apr 6;6:1-10. doi: 10.4137/BIC.S14683. eCollection 2014.

PMID:
24741338
[PubMed]
Free PMC Article
3.

An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity.

Krause U, Ryan DM, Clough BH, Gregory CA.

Cell Death Dis. 2014 Feb 27;5:e1093. doi: 10.1038/cddis.2014.67.

PMID:
24577091
[PubMed - in process]
Free PMC Article
4.

KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways.

Moody R, Zhu Y, Huang Y, Cui X, Jones T, Bedolla R, Lei X, Bai Z, Gao SJ.

PLoS Pathog. 2013;9(12):e1003857. doi: 10.1371/journal.ppat.1003857. Epub 2013 Dec 26. Erratum in: PLoS Pathog. 2014 Jan;10(1). doi:10.1371/annotation/582f0298-9999-46ea-be7e-6718608b11c5.

PMID:
24385912
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Histologic and genetic advances in refining the diagnosis of "undifferentiated pleomorphic sarcoma".

Kelleher FC, Viterbo A.

Cancers (Basel). 2013 Feb 22;5(1):218-33. doi: 10.3390/cancers5010218.

PMID:
24216705
[PubMed]
Free PMC Article
6.

Mesenchymal stem cell transformation and sarcoma genesis.

Xiao W, Mohseny AB, Hogendoorn PC, Cleton-Jansen AM.

Clin Sarcoma Res. 2013 Jul 23;3(1):10. doi: 10.1186/2045-3329-3-10.

PMID:
23880362
[PubMed]
Free PMC Article
7.

Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.

Silveira SM, Villacis RA, Marchi FA, Barros Filho Mde C, Drigo SA, Neto CS, Lopes A, da Cunha IW, Rogatto SR.

PLoS One. 2013 Jun 25;8(6):e67643. doi: 10.1371/journal.pone.0067643. Print 2013.

PMID:
23825676
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.

Guijarro MV, Dahiya S, Danielson LS, Segura MF, Vales-Lara FM, Menendez S, Popiolek D, Mittal K, Wei JJ, Zavadil J, Cordon-Cardo C, Pandolfi PP, Hernando E.

Am J Pathol. 2013 Jun;182(6):2015-27. doi: 10.1016/j.ajpath.2013.02.035.

PMID:
23708211
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Inflammatory malignant fibrous histiocytoma associated with leukemoid reaction or leukocytosis: a comprehensive review.

Hurtado-Cordovi J, Pathak P, Avezbakiyev B, Frieri M.

ISRN Oncol. 2012;2012:946019. doi: 10.5402/2012/946019. Epub 2012 Oct 14.

PMID:
23097722
[PubMed]
Free PMC Article
10.

Genetically engineered mouse models and human osteosarcoma.

Ng AJ, Mutsaers AJ, Baker EK, Walkley CR.

Clin Sarcoma Res. 2012 Oct 4;2(1):19. doi: 10.1186/2045-3329-2-19.

PMID:
23036272
[PubMed]
Free PMC Article
11.
12.

Comparison of gene expression profiling in sarcomas and mesenchymal stem cells identifies tumorigenic pathways in chemically induced rat sarcoma model.

Honoki K, Fujii H, Tohma Y, Tsujiuchi T, Kido A, Tsukamoto S, Mori T, Tanaka Y.

ISRN Oncol. 2012;2012:909453. doi: 10.5402/2012/909453. Epub 2012 Jul 17.

PMID:
22852096
[PubMed]
Free PMC Article
13.

Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming.

Zhang X, Cruz FD, Terry M, Remotti F, Matushansky I.

Oncogene. 2013 May 2;32(18):2249-60, 2260.e1-21. doi: 10.1038/onc.2012.237. Epub 2012 Jul 9.

PMID:
22777357
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Perspectives on cancer stem cells in osteosarcoma.

Basu-Roy U, Basilico C, Mansukhani A.

Cancer Lett. 2013 Sep 10;338(1):158-67. doi: 10.1016/j.canlet.2012.05.028. Epub 2012 May 29. Review.

PMID:
22659734
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Solid tumor differentiation therapy - is it possible?

Cruz FD, Matushansky I.

Oncotarget. 2012 May;3(5):559-67. Review.

PMID:
22643847
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Hiwi mediated tumorigenesis is associated with DNA hypermethylation.

Siddiqi S, Terry M, Matushansky I.

PLoS One. 2012;7(3):e33711. doi: 10.1371/journal.pone.0033711. Epub 2012 Mar 16.

PMID:
22438986
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects.

Dela Cruz F, Terry M, Matushansky I.

Differentiation. 2012 Apr;83(4):220-30. doi: 10.1016/j.diff.2012.01.001. Epub 2012 Mar 8.

PMID:
22406973
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

PPARγ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma.

Charytonowicz E, Terry M, Coakley K, Telis L, Remotti F, Cordon-Cardo C, Taub RN, Matushansky I.

J Clin Invest. 2012 Mar 1;122(3):886-98. doi: 10.1172/JCI60015. Epub 2012 Feb 1.

PMID:
22293175
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Wnt/β-catenin expression does not correlate with serum alkaline phosphatase concentration in canine osteosarcoma patients.

Piskun CM, Muthuswamy A, Huelsmeyer MK, Thompson V, Stein TJ.

PLoS One. 2011;6(10):e26106. doi: 10.1371/journal.pone.0026106. Epub 2011 Oct 11.

PMID:
22022527
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients.

Rot S, Taubert H, Bache M, Greither T, Würl P, Eckert AW, Schubert J, Vordermark D, Kappler M.

BMC Cancer. 2011 Oct 6;11:429. doi: 10.1186/1471-2407-11-429.

PMID:
21978106
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk